Switch theme
Sign up to access all valuation multiples
Episurf Medical AB is a medical device company. The company develops, manufactures, and commercializes solutions for the repair of the local cartilage damage in human joints. Its first patient-specific product portfolio, the knee portfolio, consists of the existing products Episealer Condyle Solo and Episealer Trochlea Solo, Episealer Femoral Twin, Epiguide MOS, and Epioscopy. Episealer Patellofemoral System for the treatment of osteoarthritis limited to thepatellofemoral part of the knee joint.
2009
27
Last FY Revenue $1.3M
Last FY EBITDA -$6.8M
$4.7M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Episurf Medical achieved revenue of $1.3M and an EBITDA of -$6.8M.
Episurf Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Episurf Medical valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $1.3M | XXX | XXX | XXX |
| Gross Profit | XXX | $1.1M | XXX | XXX | XXX |
| Gross Margin | XXX | 82% | XXX | XXX | XXX |
| EBITDA | XXX | -$6.8M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -508% | XXX | XXX | XXX |
| EBIT | XXX | -$8.0M | XXX | XXX | XXX |
| EBIT Margin | XXX | -594% | XXX | XXX | XXX |
| Net Profit | XXX | -$7.8M | XXX | XXX | XXX |
| Net Margin | XXX | -585% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Episurf Medical's stock price is SEK 0 (or $0).
Episurf Medical has current market cap of SEK 72.0M (or $7.4M), and EV of SEK 46.0M (or $4.7M).
See Episurf Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4.7M | $7.4M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Episurf Medical has market cap of $7.4M and EV of $4.7M.
Episurf Medical's trades at 3.5x EV/Revenue multiple, and -0.7x EV/EBITDA.
Equity research analysts estimate Episurf Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Episurf Medical's P/E ratio is not available.
See valuation multiples for Episurf Medical and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $7.4M | XXX | $7.4M | XXX | XXX | XXX |
| EV (current) | $4.7M | XXX | $4.7M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 3.5x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -0.7x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -0.6x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -0.9x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -0.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialEpisurf Medical's revenue per employee in the last FY averaged $50K, while opex per employee averaged $0.3M for the same period.
Episurf Medical's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Episurf Medical's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Episurf Medical and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -508% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $50K | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 676% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Episurf Medical acquired XXX companies to date.
Last acquisition by Episurf Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Episurf Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Episurf Medical founded? | Episurf Medical was founded in 2009. |
| Where is Episurf Medical headquartered? | Episurf Medical is headquartered in Sweden. |
| How many employees does Episurf Medical have? | As of today, Episurf Medical has 27 employees. |
| Who is the CEO of Episurf Medical? | Episurf Medical's CEO is Mr. Pal Ryfors. |
| Is Episurf Medical publicy listed? | Yes, Episurf Medical is a public company listed on STO. |
| What is the stock symbol of Episurf Medical? | Episurf Medical trades under EPIS B ticker. |
| When did Episurf Medical go public? | Episurf Medical went public in 2010. |
| Who are competitors of Episurf Medical? | Similar companies to Episurf Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Episurf Medical? | Episurf Medical's current market cap is $7.4M |
| Is Episurf Medical profitable? | Yes, Episurf Medical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
